{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:42:32Z","timestamp":1789400552520,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd005158.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T00:00:00Z","timestamp":1295395200000}}],"reference-count":55,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005158.pub3","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T05:46:23Z","timestamp":1294292783000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease"],"prefix":"10.1002","author":[{"given":"Alessandro","family":"Squizzato","sequence":"first","affiliation":[{"name":"University of Insubria; Research Center on Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical Medicine; Medicina 1 viale Borri, 57 Varese Italy 21100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tymen","family":"Keller","sequence":"additional","affiliation":[{"name":"Academical Medical Center; Cardiology; Meibergdreef 9 Postbus 22660 Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Romualdi","sequence":"additional","affiliation":[{"name":"University of Insubria; Department of Clinical Medicine; viale Borri 57 Varese Italy 21100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,19]]},"reference":[{"key":"10.1002\/14651858.CD005158.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin prevent cardiovascular disease: the association aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2005.05.091","article-title":"Differences in the management and prognosis of women and men who suffer from acute coronary syndromes","volume":"46","author":"Anand","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"13","key":"10.1002\/14651858.CD005158.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.0000029926.71825.E2","article-title":"Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups","volume":"106","author":"BuDaj","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD005158.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ahj.2005.01.044","article-title":"Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"150","author":"Lewis","year":"2005","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ahj.2005.02.044","article-title":"Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation","volume":"151","author":"Mahoney","year":"2006","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"issue":"14","key":"10.1002\/14651858.CD005158.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD005158.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019501-200409000-00008","article-title":"The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention","volume":"15","author":"Akbulut","year":"2004","journal-title":"Coronary Artery Disease"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.ahj.2005.10.021","article-title":"Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients ith stable coronary artery disease","volume":"151","author":"Azar","year":"2006","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.STR.0000209331.39894.3d","article-title":"The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy signal analysis and quality control mechanisms in the CARESS (clopidogrel and aspirin reduction emboli symptomatic carotid stenosis)","volume":"37","author":"Dittrich","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection. The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial","volume":"111","author":"Markus","year":"2005","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bjs.4810","article-title":"Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after low limb angioplasty","volume":"92","author":"Cassar","year":"2005","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0019|cit19","first-page":"115","article-title":"The influence of body mass index on outcomes and the benefit of antiplatelet therapy following percutaneous coronary intervention","volume":"18","author":"Kelly","year":"2006","journal-title":"The Journal of Invasive Cardiology"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/hrt.2005.064501","article-title":"Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment","volume":"92","author":"Mukherjee","year":"2006","journal-title":"Heart"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.amjcard.2004.05.026","article-title":"Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention","volume":"94","author":"Saw","year":"2004","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09537105310001645960","article-title":"The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease","volume":"15","author":"Jagroop","year":"2004","journal-title":"Platelets"},{"issue":"3","key":"10.1002\/14651858.CD005158.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00380-003-0704-1","article-title":"A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation","volume":"18","author":"Pekdemir","year":"2003","journal-title":"Heart & Vessels"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2005.10.047","article-title":"Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention","volume":"47","author":"Steinhubl","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0027|cit27","unstructured":"Xydakis D Papadogiannakis A Sfakianaki M Vakouti E Papachristoforou K The combination of clopidogrel and acetylsalicylic acid inhibits more effective the platelet activation in haemodialysis patients with acute coronary syndromes and high C reactive protein 41st Congress of the European Renal Association. European Dialysis and Transplantation Association. Lisbon, Portugal, May 15-18, 2004 2004 355"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005158.pub3-BIB0028|cit28","first-page":"Abstract number","article-title":"The effects of three anti-platelet drugs (aspirin, clopidogrel, dipyridamole) given singly or together on platelet and leucocyte function in healthy subjects and patients with previous ischemic stroke","volume":"1","author":"Zhao","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0029|cit29","unstructured":"Aspirin and Plavix following coronary artery bypass grafting http:\/\/www.clinicaltrial.gov"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0030|cit30","unstructured":"Randomized control trial of clopidogrel after surgery for coronary artery disease http:\/\/www.clinicaltrial.gov."},{"key":"10.1002\/14651858.CD005158.pub3-BIB0031|cit31","unstructured":"Clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease http:\/\/www.clinicaltrial.gov"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0032|cit32","unstructured":"Follow-up management of peripheral arterial intervention with clopidogrel http:\/\/www.clinicaltrial.gov"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0033|cit33","unstructured":"Secondary prevention of small subcortical strokes trial http:\/\/www.controlled-trials.com"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trails of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidrogel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD005158.pub3-BIB0036|cit36","article-title":"Ticlopidine versus oral anticoagulation for coronary stenting","author":"Cosmi","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005158.pub3-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000535","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","author":"Dorffler-Melly","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005158.pub3-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000536","article-title":"Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery","author":"Dorffler-Melly","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005158.pub3-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002071.pub2","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","author":"Dorffler-Melly","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJM200206063462309","article-title":"Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.","volume":"346","author":"Gaspoz","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"The GUSTO Investigators","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005158.pub3-BIB0044|cit44","article-title":"Thienopyridine derivates (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients","author":"Hankey","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0046|cit46","unstructured":"Higgins JPT Altman DG (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0047|cit47","first-page":"1","article-title":"Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation","volume":"40","author":"Main","year":"2004","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2125.2003.01979.x","article-title":"Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity","volume":"57","author":"Morant","year":"2003","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Main C Palmer S Griffin S Jones L Orton V Sculpher M A rapid and systematic review on clinical effectiveness and cost-effectiveness of clopidogrel used in combination with aspirin compared to aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes (ACS) (Assessment Report) National Institute for Clinical Excellence on behalf of the National Health Service, UK 2004","DOI":"10.3310\/hta8400"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD005158.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.119.1_suppl.39S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects","volume":"119","author":"Patrono","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD005158.pub3-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001272","article-title":"Cilostazol for peripheral arterial disease","author":"Robless","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005158.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003748.pub2","article-title":"Antiplatelet agents for intermittent claudication","author":"Robless","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005158.pub3-BIB0053|cit53","first-page":"CD005449","article-title":"Adenosin-diphosphate (ADP) receptor antagonists (clopidogrel, ticlopidine) for the prevention of cardiovascular disease in type 2 diabetes mellitus (Protocol)","author":"Laar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0054|cit54","article-title":"WHO Global Burden Disease Estimates","volume-title":"World Health Reports","year":"2003"},{"key":"10.1002\/14651858.CD005158.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.STR.0000109253.66918.5E","article-title":"Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration","volume":"35","author":"Zakarija","year":"2004","journal-title":"Stroke"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005158.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T00:00:00Z","timestamp":1513209600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005158.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:45:40Z","timestamp":1628545540000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005158.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,19]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005158.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD005158.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,19]]}}}